Find uplifting stories about heroes, innovations, and solutions
39 results for "lymphoma"
St. David's South Austin became the first hospital globally to enroll a patient in a groundbreaking lymphoma treatment trial. The new therapy targets cancer cells in ways previous treatments couldn't reach, offering hope to patients who've run out of options.
The FDA just approved two new treatment combinations for cancer patients who've run out of options. These approvals bring fresh hope to people battling mantle cell lymphoma.
Patients battling a rare and stubborn blood cancer just gained a powerful new option after the FDA approved the first drug in its class to treat mantle cell lymphoma. The daily pill offers hope for patients who've exhausted other treatments, with trial results showing responses lasting over a year.
The FDA just approved Beqalzi, the first BCL2 inhibitor for patients with relapsed mantle cell lymphoma who've tried other treatments. Over half the patients in trials responded to the new therapy, offering fresh hope for those with limited options.
Full House star Dave Coulier shared hopeful news after months of intensive cancer treatment. After fighting both lymphoma and throat cancer, recent scans show he's beating both diseases.
Joe Bacani was diagnosed with Hodgkin's Lymphoma at 17, inspired by a nurse who understood his battle. Now 23 years cancer-free, he's spent 18 years helping young cancer patients at Memorial Sloan Kettering.
Jurassic Park star Sam Neill announced he's completely cancer-free after a five-year battle with lymphoma, crediting breakthrough therapy that saved his life. The beloved actor says he's ready to return to the big screen.
Elise Boyse beat Hodgkin's lymphoma at 18, then channeled her experience into groundbreaking cancer research that just earned her one of America's most prestigious science scholarships. The Davidson College junior is now using chemistry to develop gentler, more effective treatments for future patients.
Hannah Everett fought Hodgkin lymphoma twice before high school. Now she's graduating from UK's College of Nursing to help children facing the same fear she once lived through.
Actor Sam Neill announced he has no cancer in his body, four years after his stage three lymphoma diagnosis nearly ended his life. The Jurassic Park star credits an innovative therapy that genetically modifies blood cells to attack cancer.
Researchers discovered a protein that acts as a natural brake on the most common blood cancer, and restoring it stopped tumors cold in the lab. The finding could help doctors predict which patients need aggressive treatment and may lead to new therapies for those who don't respond to standard care.
Aarav Vats studied between chemotherapy sessions for lymphoblastic lymphoma and scored 96.6% on India's CBSE board exams. His teachers sent voice notes to hospital rooms, and he studied whenever his body had strength.
Doctors are finally cracking the code on rare T-cell lymphomas that have resisted treatment for decades. A team of researchers across eight major U.S. medical centers is mapping personalized treatments that could transform survival rates.
Mark Palm survived B-cell lymphoma and found healing through pickleball. Now he's competing at the U.S. Open while running a life-saving medical flight program that brings emergency care to 200,000 people in remote Papua New Guinea.
A breakthrough "off-the-shelf" CAR-T therapy eliminated residual cancer cells three times more effectively than standard care in lymphoma patients. The treatment could prevent cancer recurrence in high-risk patients for the first time.
A groundbreaking clinical trial has just given Japanese patients with an aggressive form of lymphoma a powerful new treatment option. The SUNMO trial results convinced Japan's health ministry to approve the therapy as a new standard of care.
Nathan Yuill raised $2,000 in just 24 hours to fill Easter baskets for nearly every child at his Alaska hospital. The 12-year-old is two treatments away from remission after battling stage-4 lymphoma.
Professional footballer David Brooks was diagnosed with Stage Two Hodgkin lymphoma at age 24, watching from the stands as his Wales teammates played in the 2022 World Cup. Now he's not just back on the pitch—he's playing better than ever before.
Welsh footballer David Brooks missed the 2022 World Cup while recovering from Stage Two Hodgkin lymphoma and grueling chemotherapy. Four years later, he's not just back on the pitch—he's playing the best football of his career.
A man who beat non-Hodgkin's lymphoma twice shows up every year to honor the students who fundraise for cancer research. His message is simple: "Life is good."
Showing 20 of 39